Market Overview

Recap: Fulgent Genetics Q4 Earnings


Fulgent Genetics (NASDAQ:FLGT) reported Q4 results.

Quarterly Results

• Earnings per share were up 500% over the past year to $0.04, which in line with the estimate.

• Revenue of $8,387,000 up by 47.68% from the same period last year, which missed the estimate of $8,510,000.

Conference Call Details

• Date: Mar 10, 2020

• Time: 8:05 PM ET

• Webcast URL:

Recent Stock Performance

• 52-week high was at $20.60

• 52-week low was at $4.71

• Price action over last quarter: Up 17.22%

Company Overview

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to a disease and enhanced disease treatment and prognosis.


Related Articles (FLGT)

View Comments and Join the Discussion!

Posted-In: Earnings News After-Hours Center

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at